Thanks to RFK Jr. and TRUTH MEDIA WORLDWIDE the CDC has finally admitted MERCURY IN VACCINES is a horrible practice – votes to remove it
By sdwells // 2025-06-30
Copy
 
  1. Advisory Committee Vote: The Advisory Committee on Immunization Practices (ACIP) unanimously recommended eliminating thimerosal (a mercury-based preservative) from CDC-endorsed flu vaccines, citing safety concerns despite opposition from some members like Dr. Cody Meissner, who disputed conclusive harm.
  2. Safety Debate: Critics, including HHS official Lyn Redwood and CDC adviser Dr. Robert Malone, highlighted risks of chronic thimerosal exposure, linking it to neurodevelopmental issues like tics. The CDC initially posted but later removed an unapproved document claiming "no association" between thimerosal and autism.
  3. Industry Status: While 95% of 2024–2025 flu vaccines are already thimerosal-free, manufacturers like Sanofi and Seqirus still produce preservative-containing shots. The CDC’s implementation of the recommendation will take time.
  4. Political Context: Health Secretary Robert F. Kennedy Jr., a longtime critic of thimerosal, recently replaced all 17 ACIP members and raised concerns about cumulative mercury exposure from annual flu shots. The vote marks a shift toward fully phasing out thimerosal in federally recommended vaccines.

Federal panel recommends removal of thimerosal from flu vaccines amid ongoing safety debate

A key federal advisory committee has voted to recommend eliminating thimerosal, a mercury-based preservative, from flu vaccines—despite lingering disagreements over its safety. The Advisory Committee on Immunization Practices (ACIP), which guides U.S. vaccine policy, unanimously endorsed thimerosal-free formulations during a recent meeting, citing concerns about repeated exposure, particularly for vulnerable groups. The move comes 25 years after the Centers for Disease Control and Prevention (CDC) first urged manufacturers to phase out the preservative, yet it remains in a small fraction of flu shots. The ACIP reaffirmed its broad recommendation for annual flu vaccinations but emphasized a shift toward thimerosal-free options, noting that 95% of doses in the 2024–2025 season already exclude the preservative. Advocates, including Health Secretary Robert F. Kennedy Jr., have long criticized thimerosal’s safety, pointing to studies linking it to neurological effects. Lyn Redwood, a Department of Health and Human Services official, presented evidence to the committee ahead of the vote, highlighting research associating thimerosal with tics and mixed neurodevelopmental outcomes in children. “We do have a risk of repeated exposure to this,” said Dr. Robert Malone, a CDC adviser. “It’s not just a one-time administration, but potential chronic exposure on an annual basis.” Several panel members, including Retsef Levi, agreed, stating, “We need to control the controllable sources of exposure.”

Growing calls for precautionary action

The committee’s vote followed internal divisions. Dr. Cody Meissner opposed the change, arguing that “no scientific evidence proves thimerosal causes harm.” A CDC document initially stating that thimerosal does not cause autism or neurodevelopmental disorders was removed before the meeting after officials acknowledged it lacked proper approval. Vicky Pebsworth abstained from voting, citing insufficient discussion, while Dr. Meissner cast the sole dissenting vote. The CDC will now consider the recommendation, though manufacturers like Sanofi and Seqirus, which still produce thimerosal-containing shots, have not publicly responded. The debate occurs against a backdrop of broader political shifts. Health Secretary Kennedy, who recently replaced all 17 ACIP members, has repeatedly warned about cumulative mercury exposure, citing a study showing elevated brain mercury levels in monkeys given thimerosal. Thimerosal, which is 50% mercury by weight, was widely used in vaccines until the early 2000s, when most U.S. manufacturers voluntarily phased it out as a precaution. The ACIP’s vote marks a formal step toward ending its use entirely in CDC-recommended vaccines, reflecting both evolving science and heightened public scrutiny. While the decision may reassure critics, it leaves unanswered questions about the preservative’s legacy and the balance between precaution and access. For now, the CDC’s final ruling will determine whether thimerosal’s limited role in flu vaccines—often reserved for multi-dose vials—comes to a close. Bookmark Vaccines.news to your favorite independent websites for updates on experimental gene therapy injections that contain spike prions and mercury and lead to turbo cancer, autism and Long-Vax-Syndrome. Sources for this article include: YourNews.com 1 YourNews.com 2 FoxNews.com
Copy